These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 106951)

  • 1. Medulloblastoma: treatment results and effect on normal tissues.
    Cumberlin RL; Luk KH; Wara WM; Sheline GE; Wilson CB
    Cancer; 1979 Mar; 43(3):1014-20. PubMed ID: 106951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of very young children with medulloblastoma (primitive neuroectodermal tumor of the posterior fossa) treated with craniospinal irradiation.
    Saran FH; Driever PH; Thilmann C; Mose S; Wilson P; Sharpe G; Adamietz IA; Böttcher HD
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):959-67. PubMed ID: 9869216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy.
    Wara WM; Le QT; Sneed PK; Larson DA; Prados MD; Levin VA; Edwards MS; Weil MD
    Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):551-6. PubMed ID: 7928485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Undernutrition and Pubertal Timing in Female Survivors of Medulloblastoma and Other Embryonal Tumors.
    Zhu J; Feldman HA; Chordas C; Wassner AJ; Manley PE; Cohen LE
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3650-9. PubMed ID: 32706870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medulloblastoma--treatment and prognosis. A study of seventeen cases in ten years.
    Probert JC; Lederman M; Bagshaw MA
    Calif Med; 1973 Jan; 118(1):14-7. PubMed ID: 4631185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management.
    Kopelson G; Linggood RM; Kleinman GM
    Cancer; 1983 Jan; 51(2):312-9. PubMed ID: 6401586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of radiation therapy for medulloblastoma].
    Shibamoto Y; Abe M; Tsutsui K; Ono K; Takahashi M
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2491-8. PubMed ID: 2614186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medulloblastoma. A review of the LDS hospital experience.
    Brown RC; Gunderson L; Plenk HP
    Cancer; 1977 Jul; 40(1):56-60. PubMed ID: 880571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the therapeutic ratio of craniospinal irradiation in medulloblastoma.
    Maor MH; Fields RS; Hogstrom KR; van Eys J
    Int J Radiat Oncol Biol Phys; 1985 Apr; 11(4):687-97. PubMed ID: 3980265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma.
    Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ
    J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival.
    Hughes EN; Shillito J; Sallan SE; Loeffler JS; Cassady JR; Tarbell NJ
    Cancer; 1988 May; 61(10):1992-8. PubMed ID: 3129177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses.
    Sethi RV; Giantsoudi D; Raiford M; Malhi I; Niemierko A; Rapalino O; Caruso P; Yock TI; Tarbell NJ; Paganetti H; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):655-63. PubMed ID: 24521681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control of low dose craniospinal irradiation for low risk medulloblastoma.
    Benk V; Bouhnik H; Raquin MA; Kalifa C; Habrand JL
    Br J Radiol; 1995 Sep; 68(813):1009-13. PubMed ID: 7496681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
    Massimino M; Gandola L; Collini P; Seregni E; Marchianò A; Serra A; Pignoli E; Spreafico F; Pallotti F; Terenziani M; Biassoni V; Bombardieri E; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):404-10. PubMed ID: 17601681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopenia in children who have undergone posterior fossa or craniospinal irradiation for brain tumors.
    Krishnamoorthy P; Freeman C; Bernstein ML; Lawrence S; Rodd C
    Arch Pediatr Adolesc Med; 2004 May; 158(5):491-6. PubMed ID: 15123484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma.
    Packer RJ; Sutton LN; Goldwein JW; Perilongo G; Bunin G; Ryan J; Cohen BH; D'Angio G; Kramer ED; Zimmerman RA
    J Neurosurg; 1991 Mar; 74(3):433-40. PubMed ID: 1847194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
    Oyharcabal-Bourden V; Kalifa C; Gentet JC; Frappaz D; Edan C; Chastagner P; Sariban E; Pagnier A; Babin A; Pichon F; Neuenschwander S; Vinchon M; Bours D; Mosseri V; Le Gales C; Ruchoux M; Carrie C; Doz F
    J Clin Oncol; 2005 Jul; 23(21):4726-34. PubMed ID: 16034048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
    Douglas JG; Barker JL; Ellenbogen RG; Geyer JR
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1161-4. PubMed ID: 15001259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.